Somatics LLC is a leading global innovator and distributor of Electroconvulsive Therapy (ECT) devices, with a rich history dating back to 1938. Their FDA-cleared Thymatron device is designed to effectively treat severe depression and catatonia in patients aged 13 and above, particularly those who are treatment-resistant or in need of rapid treatment response.
With a strong emphasis on safety and efficiency, the Thymatron instrument boasts multiple layers of error protection and advanced computer methods that ensure optimal stimulus delivery, seizure quality analysis, and seizure endpoint determination. Somatics LLC is committed to providing secure and reliable medical solutions, prioritizing patient well-being and recovery.
Generated from the website